Effect of the CYP3A inhibitor ketoconazole on the pharmacokinetics and pharmacodynamics of bortezomib in patients with advanced solid tumors: A prospective, multicenter, open-label, randomized, two-way crossover drug—drug interaction study

✍ Scribed by Karthik Venkatakrishnan; Michael Rader; Ramesh K. Ramanathan; Suresh Ramalingam; Eric Chen; William Riordan; William Trepicchio; Michael Cooper; Michael Karol; Lisa von Moltke; Rachel Neuwirth; Merrill Egorin; Gurkamal Chatta

• Book ID: 113544086
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 163 KB
• Volume: 31
• Category: Article
• ISSN: 0149-2918
• DOI: 10.1016/j.clinthera.2009.11.012